These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Levamisole--immunotherapy for everyone?]. Brincker H Ugeskr Laeger; 1977 Feb; 139(9):517-20. PubMed ID: 320738 [No Abstract] [Full Text] [Related]
3. Letter: Immunotherapy with levamisole. Arnold HL N Engl J Med; 1976 Feb; 294(8):447. PubMed ID: 1246321 [No Abstract] [Full Text] [Related]
4. Chemo-immunotherapy with levamisole in metastatic breast carcinoma: a controlled clinical trial. Paterson AH; Edwards AM; Nutting M; Schinnour D; Takats L; McClelland A Cancer Clin Trials; 1980; 3(1):5-10. PubMed ID: 6993035 [TBL] [Abstract][Full Text] [Related]
5. The reticuloendothelial system, cancer and cancer immunotherapy. Amery WK J Reticuloendothel Soc; 1977 Jun; 21(6):417-21. PubMed ID: 886546 [No Abstract] [Full Text] [Related]
6. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. II. Lymphocyte subpopulations. Balaram P; Padmanabhan TK; Vasudevan DM Neoplasma; 1988; 35(2):235-42. PubMed ID: 3259681 [TBL] [Abstract][Full Text] [Related]
7. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer--immune responses. Balaram P; Remani P; Padmanabhan TK; Vasudevan DM Neoplasma; 1988; 35(6):617-25. PubMed ID: 3221935 [TBL] [Abstract][Full Text] [Related]
8. Preliminary evaluation of immunotherapy in patients with Hodgkin's disease. Zywicka-Lopaciuk H; Konopka L; Karpowicz M; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Małkowska-Zwierz W; Pawelski S Arch Immunol Ther Exp (Warsz); 1981; 29(6):739-55. PubMed ID: 7349093 [TBL] [Abstract][Full Text] [Related]
9. Five-year experience with levamisole in cancer patients. Debois JM Ther Hung; 1981; 29(1):15-20. PubMed ID: 7188236 [No Abstract] [Full Text] [Related]
11. Cancer immunotherapy. Stewart TH Can Med Assoc J; 1980 Jan; 122(2):157. PubMed ID: 7363206 [No Abstract] [Full Text] [Related]
12. The place of chemotherapy associated with active immunotherapy with levamisol in advanced bladder cancer. Giannopoulos A; Lykourinas M; Kioupkiolis G; Dimopoulos C Prog Clin Biol Res; 1984; 162B():123-4. PubMed ID: 6504892 [No Abstract] [Full Text] [Related]
13. Levamisole as adjuvant to chemotherapy for canine lymphosarcoma. MacEwen EG; Hayes AA; Mooney S; Patnaik A; Kurzman I; Hardy WD J Biol Response Mod; 1985 Aug; 4(4):427-33. PubMed ID: 3839843 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of effects of levamisole and surgery on canine mammary cancer. MacEwen EG; Harvey HJ; Patnaik AK; Mooney S; Hayes A; Kurzman I; Hardy WD J Biol Response Mod; 1985 Aug; 4(4):418-26. PubMed ID: 4031952 [TBL] [Abstract][Full Text] [Related]
15. Surgical adjuvant immunotherapy for lung cancer: a review. Takita H Curr Surg; 1984; 41(4):254-61. PubMed ID: 6383721 [No Abstract] [Full Text] [Related]
16. Levamisole in the treatment of cancer: anything new? (Review). De Brabander M; De Crée J; Vandebroek J; Verhaegen H; Janssen PA Anticancer Res; 1992; 12(1):177-87. PubMed ID: 1567166 [TBL] [Abstract][Full Text] [Related]
17. Levamisole as an immunotherapeutic agent in the treatment of cancer. Amery WK World J Surg; 1977 Sep; 1(5):597-604. PubMed ID: 272084 [No Abstract] [Full Text] [Related]
19. Role of levamisole immunotherapy as an adjuvant to radiotherapy in oral cancer. I. A three-year clinical follow up. Padmanabhan TK; Balaram P; Vasudevan DM Neoplasma; 1987; 34(5):627-32. PubMed ID: 3696303 [TBL] [Abstract][Full Text] [Related]